Citigroup’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-98
| Closed | -$143 | – | 4994 |
|
|
2022
Q4 | $143 | Sell |
98
-453
| -82% | -$661 | ﹤0.01% | 4816 |
|
|
2022
Q3 | $2K | Sell |
551
-495
| -47% | -$1.8K | ﹤0.01% | 4742 |
|
|
2022
Q2 | $4K | Sell |
1,046
-1,307
| -56% | -$5K | ﹤0.01% | 4947 |
|
|
2022
Q1 | $11K | Sell |
2,353
-7,784
| -77% | -$36.4K | ﹤0.01% | 4711 |
|
|
2021
Q4 | $37K | Buy |
10,137
+5,931
| +141% | +$21.6K | ﹤0.01% | 4440 |
|
|
2021
Q3 | $34K | Buy |
4,206
+2,199
| +110% | +$17.8K | ﹤0.01% | 4221 |
|
|
2021
Q2 | $23K | Sell |
2,007
-31,587
| -94% | -$362K | ﹤0.01% | 4554 |
|
|
2021
Q1 | $311K | Buy |
+33,594
| New | +$311K | ﹤0.01% | 3119 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 4935 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 4982 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 5017 |
|
|
2016
Q2 | – | Sell |
-1
| Closed | – | – | 5327 |
|
|
2016
Q1 | $0 | Sell |
1
-13
| -93% | – | ﹤0.01% | 5646 |
|
|
2015
Q4 | $2K | Buy |
14
+8
| +133% | +$1.14K | ﹤0.01% | 5169 |
|
|
2015
Q3 | $1K | Buy |
+6
| New | +$1K | ﹤0.01% | 5094 |
|
|
2015
Q2 | – | Sell |
-59
| Closed | -$31K | – | 5782 |
|
|
2015
Q1 | $31K | Buy |
59
+12
| +26% | +$6.31K | ﹤0.01% | 4144 |
|
|
2014
Q4 | $26K | Buy |
47
+39
| +488% | +$21.6K | ﹤0.01% | 4473 |
|
|
2014
Q3 | $12K | Sell |
8
-2
| -20% | -$3K | ﹤0.01% | 4539 |
|
|
2014
Q2 | $14K | Sell |
10
-184
| -95% | -$258K | ﹤0.01% | 4391 |
|
|
2014
Q1 | $268K | Buy |
194
+110
| +131% | +$152K | ﹤0.01% | 2617 |
|
|
2013
Q4 | $84K | Buy |
84
+74
| +740% | +$74K | ﹤0.01% | 3826 |
|
|
2013
Q3 | $10K | Buy |
+10
| New | +$10K | ﹤0.01% | 4576 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5157 |
|